|
| | SR0176 | | LRB104 08264 MST 18314 r |
|
|
| 1 | | SENATE RESOLUTION |
| 2 | | WHEREAS, Facioscapulohumeral muscular dystrophy, or FSHD, |
| 3 | | is a genetic neuromuscular disease that leads to the weakening |
| 4 | | of skeletal muscles; and |
| 5 | | WHEREAS, FSHD gets its name from the muscles affected in |
| 6 | | the face (facio), shoulder girdle (scapulo), and upper arms |
| 7 | | (humeral); and |
| 8 | | WHEREAS, Individuals with FSHD, like those with other rare |
| 9 | | disorders, often experience challenges in obtaining a timely |
| 10 | | diagnosis, which takes an average of nine years for this |
| 11 | | condition; and |
| 12 | | WHEREAS, An estimated 1 in 8,000 individuals, or 40,000 |
| 13 | | Americans, are living with FSHD; and |
| 14 | | WHEREAS, FSHD symptoms can develop at any age, from |
| 15 | | infancy through adulthood, and can differ in the pattern and |
| 16 | | severity of muscle weakness; and |
| 17 | | WHEREAS, Approximately 20 percent of individuals with FSHD |
| 18 | | will become dependent on a wheelchair or scooter; and |
| 19 | | WHEREAS, Patients with FSHD can develop respiratory |